|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A eontempornry analysis of the ability of preoperative Senlnl CA125 to predict primary eytoreduet- ire outcome in patients with advanced ovarian, tubal and peritoneal carcinoma显示文摘 | Chi DS Zivanovie O Palayekar R | 2009 | Gynecol Oneol2009，112，1： | 1 |
| 2 | A contemporary analysis of the ability of preoperative serum CA-125to predict primary cytoreductive outcome in patients with advanced ovarian,tubal and peritoneal carcinoma显示文摘 | Chi DS Zivanovic O Palayekar MJ | 2009 | Gynecol Oncol2009，112，1： | 1 |
| 3 | A eontempornry analysis of the ability of preoperative Senlnl CA125 to predict primary eytoreduetive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma 显示文摘 | Chi DS Zivanovie O Palayekar R | 2009 | Gynecol Oneol2009，112，1： | 1 |
| 4 | The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology显示文摘 | Chi DS Barakat RR Palayekar M J | 2008 | Int J Gynecol Cancer2008，18，2： | 1 |
| 5 | The emerging role of epidermal growthfactor receptor inhibitors in ovarian cancer显示文摘 | Palayekar MJ Herzog TJ | 2008 | Int J GynecolCancer2008，18，5： | 1 |
| 6 | A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian,tubal and peritoneal carcinoma显示文摘 | Chi DS Zivanovic O Palayekar MJ | 2009 | Gynecol Oncol2009，112，： | 1 |
| 7 | A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma 显示文摘 | Chi DS Zivanovie O Palayekar MJ | 2009 | Gynecol Oncol2009，112，1： | 1 |
| 8 | A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian,tubal and peritoneal carcinoma显示文摘 | Chi DS Zivanovic O Palayekar M J | 2009 | Gynecol Oncol2009，112，： | 1 |
| 9 | A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma 显示文摘 | Chi DS Zivanovic O Palayekar MJ | 2009 | Gynecol Ontol2009，112，1： | 1 |
| 10 | A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian,tubal and peritoneal carcinoma显示文摘 | Chi DS Zivanovic O Palayekar MJ | 2009 | Gynecol Oncol2009，112，1： | 1 |
| 11 | A contemporary anal-ysis of the ability of preoperative serum CA125 to predict primarycytoreductive outcome in patients with advanced ovarian,tube andperitoneal carcinoma显示文摘 | Chi DS Zivanovic 0 Palayekar MJ | 2009 | Gynecol Oncol2009，112，4： | 1 |
| 12 | A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma显示文摘 | Dennis S. Chi Oliver Zivanovic Meena J. Palayekar Eric L. Eisenhauer Nadeem R. Abu-Rustum Yukio Sonoda Douglas A. Levine Mario M. Leitao Carol L. Brown Richard R. Barakat | 2008 | Gynecologic Oncology2008，，： | 1 |
| 13 | The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology显示文摘 | D. S. CHI R. R. BARAKAT M. J. PALAYEKAR D. A. LEVINE Y. SONODA K. ALEKTIAR C. L. BROWN N. R. ABU-RUSTUM | 2008 | International Journal of Gynecological Cancer2008，，2： | 1 |
| 14 | A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian , tubal and peritoneal carcinoma 显示文摘 | Chi D S Zivanovic O Palayekar M J | 2009 | Gynecol Oncol2009，112，1： | 1 |
| 15 | A contemporary a nalysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian,tubal and peritoneal carcinoma显示文摘 | Chi DS Zivanovic O Palayekar MJ | 2009 | Gy- necol Oncol2009，112，2： | 1 |
| 16 | The incidence of pelvic lymphnode metastasis by FIGO staging for patients with ade- quately surgically staged endometrial adenocarcinoma of endometrioid histology显示文摘 | Chi DS Barakat RR Palayekar MJ | 2008 | Int J Gynecol Cancer2008，18，2： | 1 |
| 17 | The emerging role of epidermal growthfactor receptor inhibitors in ovarian cancer显示文摘 | Palayekar MJ Herzog TJ | 2008 | Int J Gynecol Cancer2008，18，5： | 1 |
| 18 | A eontempo- rar'y analysis of the ability of preoperative serum CA - 125 to pre- dict primary cytoreductive outcome in patients with advanced ovari- an, tubal and peritoneal carcinoma 显示文摘 | CHI D S ZIVANOVIC O PALAYEKAR M J | 2009 | Gynecol Oncol2009，112，： | 1 |
| 19 | The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology 显示文摘 | Chi DS Barakat RR Palayekar M J | 2008 | Int J Gynecol Cancer2008，18，2： | 1 |
| 20 | Comparison of four nonculture diagnostic tests for Chlamydia trachomatis infection显示文摘 | Palayekar VV Joshi JV Hazari KT | 2000 | J Assoc Physicians India2000，48，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员